China Universal Asset Management Co., Ltd. Autolus Therapeutics PLC Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 27,034 shares of AUTL stock, worth $93,267. This represents 0.02% of its overall portfolio holdings.
Number of Shares
27,034
Previous 27,034
-0.0%
Holding current value
$93,267
Previous $172,000
-0.0%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding AUTL
# of Institutions
123Shares Held
168MCall Options Held
411KPut Options Held
67.6K-
Syncona Portfolio LTD Guernsey, Channel Islands, X021.3MShares$73.6 Million90.76% of portfolio
-
Blackstone Inc New York, NY20.5MShares$70.7 Million0.54% of portfolio
-
Deep Track Capital, LP Greenwich, CT15.3MShares$52.7 Million3.22% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.3MShares$42.6 Million0.95% of portfolio
-
Wellington Management Group LLP Boston, MA10.8MShares$37.1 Million0.01% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $314M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...